Expression of Multidrug Resistance-Associated Protein (MRP) in Brain Microvessel Endothelial Cells

Multidrug resistance-associated protein (MRP) is a recently identified drug efflux transport system that actively transports organic acids and selected glucuronide or glutathione conjugates out of the cell. The current study presents, for the first time, both functional and biochemical data demonstr...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 1998-02, Vol.243 (3), p.816-820
Main Authors: Huai-Yun, Han, Secrest, David T., Mark, Karen S., Carney, Debra, Brandquist, Christine, Elmquist, William F., Miller, Donald W.
Format: Article
Language:English
Subjects:
Animals
ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism
ATP-Binding Cassette Transporters - antagonists & inhibitors
ATP-Binding Cassette Transporters - genetics
ATP-Binding Cassette Transporters - metabolism
Blood-Brain Barrier
Brain - blood supply
Cattle
Cells, Cultured
Drug Resistance, Multiple
Endothelium, Vascular - metabolism
Fluorescein - metabolism
Humans
Indomethacin - pharmacology
Kinetics
Microcirculation - metabolism
Multidrug Resistance-Associated Proteins
Polymerase Chain Reaction
Probenecid - pharmacology
RNA - analysis
Tumor Cells, Cultured
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Multidrug resistance-associated protein (MRP) is a recently identified drug efflux transport system that actively transports organic acids and selected glucuronide or glutathione conjugates out of the cell. The current study presents, for the first time, both functional and biochemical data demonstrating the presence of MRP in the brain microvessel endothelial cells that form the blood-brain barrier (BBB). Using known MRP inhibitors, such as indomethacin and probenecid, fluorescein accumulation in primary cultured bovine brain microvessel endothelial cell (BBMEC) monolayers was significantly enhanced compared to control. The specificity of the MRP inhibitors on cellular fluorescein accumulation was confirmed using both MRP positive (Panc-1) and MRP negative (KBv) cell lines. Furthermore, western blot analysis using a specific antibody for MRP (MRPm6) and RT-PCR studies using a complementary sequence probe for human MRP demonstrate the expression of MRP in BBMEC. Previous studies have demonstrated the significance of the P-glycoprotein drug efflux transporter in the BBB. Given its function as a drug efflux transport system, it is anticipated that MRP in the BBB will also have an important role in limiting the exposure of the brain to many endogenous and exogenous compounds, including both toxic and therapeutic agents.
ISSN:0006-291X
1090-2104
DOI:10.1006/bbrc.1997.8132